Trials Data on COPD Leave Primary Care Docs in the Dark

Flare-ups and breathing difficulties were common among patients seen at primary care practices, suggesting a need for better evidence to guide treatment for the condition, a new analysis found.

Related Keywords

United States ,Illinois ,Ann Arbor ,Michigan ,Houston ,Texas ,Baylor College Of Medicine ,Americans ,American ,Jerry Krishnan ,Meilan Han ,Nicola Hanania ,Glaxosmithkline ,Amgen ,National Health ,Genentech ,Boehringer Ingelheim ,Novartis ,University Of Michigan ,Department Of Family ,Division Of Pulmonary ,Pfizer ,Astrazeneca ,University Of Minnesota ,Dartnet Institute ,Centers For Disease ,University Of Illinois Chicago ,Drug Administration ,American Lung Association ,Johnson ,Community Health ,Novo Nordisk ,Critical Care ,Medscape Medical ,Barbara Yawn ,Window Onto Patient Burden ,Disease Control ,Family Medicine ,Patient Experience ,Illinois Chicago ,Airways Clinical Research Center ,Baylor College ,Nutrition Examination Surveys ,Optimum Patient Care Global ,Chronic Obstructive Pulmonary Disease Copd ,Chronic Obstructive Pulmonary Disease ,Copd ,Chronic Obstructive Lung Disease ,Dyspnea ,Hypertension ,Clinical Research ,Clinical Trials ,Linical Studies ,Healthcare And Medical Technology ,Ealth And Medical Tech ,Ealth And Med Tech ,Ealth And Medical Technology ,Physical Medicine And Rehabilitation ,Hysiatry ,Primary Care ,Pulmonary Rehabilitation ,Weha ,